{"id":"https://openalex.org/W4234479740","doi":"https://doi.org/10.2174/978160805159511001010156","title":"Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments","display_name":"Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments","publication_year":2010,"publication_date":"2010-08-18","ids":{"openalex":"https://openalex.org/W4234479740","doi":"https://doi.org/10.2174/978160805159511001010156"},"language":"en","primary_location":{"id":"doi:10.2174/978160805159511001010156","doi":"https://doi.org/10.2174/978160805159511001010156","is_oa":false,"landing_page_url":"https://doi.org/10.2174/978160805159511001010156","pdf_url":null,"source":{"id":"https://openalex.org/S4306462908","display_name":"BENTHAM SCIENCE PUBLISHERS eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in CNS Drug Discovery","raw_type":"book-chapter"},"volume":null,"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037881697","display_name":"Karine M. Fabio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karine Fabio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Christophe Guillon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christophe Guillon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058193129","display_name":"Shi\u2010fang Lu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shi-fang Lu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010453110","display_name":"Ned D. Heindel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ned D. Heindel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Marvin Miller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marvin Miller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069720283","display_name":"Craig F. Ferris","orcid":"https://orcid.org/0000-0001-9744-5214","observed_orcids":["https://orcid.org/0000-0001-9744-5214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Craig F. Ferris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108912848","display_name":"Michael Brownstein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael J. Brownstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5048941184","display_name":"Carrie Gar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carrie Gar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6726,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.80530973,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":null,"issue":null,"first_page":"156","last_page":"183"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.45019999146461487,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.45019999146461487,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.2142000049352646,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11541","display_name":"Neuroendocrine regulation and behavior","score":0.15410000085830688,"subfield":{"id":"https://openalex.org/subfields/3207","display_name":"Social Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vasopressin-receptor-antagonists","display_name":"vasopressin receptor antagonists","score":0.9089999794960022},{"id":"https://openalex.org/keywords/vasopressin-v1a-receptor","display_name":"vasopressin V1a receptor","score":0.871999979019165},{"id":"https://openalex.org/keywords/vasopressin-v1b-receptor","display_name":"vasopressin V1b receptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.6389999985694885},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hypothalamic-pituitary-adrenal-axis","display_name":"hypothalamic-pituitary-adrenal axis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/chronic-psychological-stress","display_name":"chronic psychological stress","score":0.8450000286102295},{"id":"https://openalex.org/keywords/neural-adaptation","display_name":"neural adaptation","score":0.7910000085830688},{"id":"https://openalex.org/keywords/corticotropin-releasing-factor","display_name":"corticotropin-releasing factor","score":0.8610000014305115},{"id":"https://openalex.org/keywords/limbic-system","display_name":"limbic system","score":0.9390000104904175},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.7269999980926514},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.925000011920929},{"id":"https://openalex.org/keywords/clinical-candidates","display_name":"clinical candidates","score":0.671999990940094},{"id":"https://openalex.org/keywords/patents","display_name":"patents","score":0.46700000762939453}],"concepts":[{"id":"https://openalex.org/C2776370428","wikidata":"https://www.wikidata.org/wiki/Q21124841","display_name":"Vasopressin","level":2,"score":0.6900014281272888},{"id":"https://openalex.org/C2779881253","wikidata":"https://www.wikidata.org/wiki/Q1587028","display_name":"Vasopressin Antagonists","level":4,"score":0.6154113411903381},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46090611815452576},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.37597984075546265},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3387403190135956},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.3274288475513458},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.15804386138916016},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1557864248752594},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.10828909277915955},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.05402648448944092}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2174/978160805159511001010156","doi":"https://doi.org/10.2174/978160805159511001010156","is_oa":false,"landing_page_url":"https://doi.org/10.2174/978160805159511001010156","pdf_url":null,"source":{"id":"https://openalex.org/S4306462908","display_name":"BENTHAM SCIENCE PUBLISHERS eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in CNS Drug Discovery","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2069722780","https://openalex.org/W2554715129","https://openalex.org/W2329349477","https://openalex.org/W2093472917","https://openalex.org/W2021240950","https://openalex.org/W3138981265","https://openalex.org/W4404710197","https://openalex.org/W2036871700","https://openalex.org/W2106400925","https://openalex.org/W1594629709"],"abstract_inverted_index":{"A":[0],"compelling":[1],"case":[2],"for":[3,16,55,61,141,150,154,192,224],"the":[4,17,67,107,162,218,230],"potential":[5],"utility":[6],"of":[7,19,35,42,71,85,110,126,185,232],"vasopressin":[8,56,111,214],"(AVP)":[9],"antagonists":[10,57],"as":[11,58,139],"a":[12,59,178,209],"novel":[13],"therapeutic":[14],"class":[15,236],"treatment":[18,211],"stress-related":[20,155],"affective":[21,156],"illness":[22,157],"has":[23],"emerged":[24],"based":[25],"on":[26],"observations":[27],"in":[28,32,44,78,82,116,121,135,217,234,250],"depressed":[29],"individuals,":[30],"findings":[31],"animal":[33,83,136],"models":[34,84,137],"anxiety":[36,62,86,166],"and":[37,39,63,69,81,87,113,124,129,143,167,176,199,246],"depression,":[38,88],"an":[40],"understanding":[41],"changes":[43],"hypothalamic-pituitary-adrenal":[45],"(HPA)":[46],"axis":[47],"regulation":[48,123],"under":[49],"chronic":[50,76,103],"stress.":[51],"The":[52,146,241],"scientific":[53],"bases":[54],"pharmacotherapy":[60],"depression":[64,168],"include:":[65],"1)":[66],"neuroadaptation":[68],"dysregulation":[70],"HPA":[72,99,122],"function":[73,100],"that":[74,91,208],"accompanies":[75],"stress":[77],"affected":[79],"humans":[80],"2)":[89],"recognition":[90],"AVP,":[92],"not":[93,196],"corticotrophin":[94],"releasing":[95],"factor":[96],"(CRF),":[97],"drives":[98],"associated":[101],"with":[102],"psychological":[104],"stress,":[105],"3)":[106],"CNS":[108,219],"localization":[109],"V1a":[112],"V1b":[114],"receptors":[115],"limbic":[117],"system":[118],"regions":[119],"involved":[120],"control":[125],"social":[127],"behaviors,":[128],"4)":[130],"preclinical":[131],"data":[132],"showing":[133],"efficacy":[134],"employed":[138],"screens":[140],"anxiolytic":[142],"antidepressant":[144],"activity.":[145],"public":[147],"health":[148],"need":[149],"new":[151,210],"pharmaceutical":[152],"treatments":[153],"is":[158,239],"well":[159],"documented.":[160],"In":[161,227],"United":[163],"States":[164],"alone,":[165],"affect":[169],"some":[170],"35":[171],"million":[172],"people":[173],"each":[174],"year":[175],"carry":[177],"conservatively":[179],"estimated":[180],"annual":[181],"total":[182],"economic":[183],"burden":[184],"at":[186],"least":[187],"$125":[188],"billion.":[189],"Existing":[190],"pharmacotherapies":[191],"both":[193],"indications":[194],"are":[195,253],"uniformly":[197],"effective":[198],"frequently":[200],"have":[201],"undesirable":[202],"side":[203],"effects.":[204],"These":[205],"limitations":[206],"demonstrate":[207],"approach":[212],"through":[213],"receptor":[215],"antagonism":[216],"may":[220],"offer":[221],"significant":[222],"opportunities":[223],"improved":[225],"outcomes.":[226],"this":[228,235],"review,":[229],"development":[231],"compounds":[233,248],"since":[237],"2005":[238],"considered.":[240],"most":[242],"advanced":[243],"clinical":[244],"candidates":[245],"newer":[247],"described":[249],"recent":[251],"patents":[252],"presented.":[254]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2022-05-12T00:00:00"}